| Name | 3α,7α,12α-trihydroxy-5β-cholestan-26-oic acid |
|---|---|
| Synonyms |
3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oic acid
Trihydroxycholestanoic acid |
| Description | Trihydroxycholestanoic acid is an endogenous metabolite present in Blood that can be used for the research of Zellweger Syndrome, Refsum Disease, D Bifunctional Protein Deficiency and Infantile Refsum Disease[1][2][3][4]. |
|---|---|
| Related Catalog | |
| In Vitro | Endogenous metabolites is defined as those that are annotated by Kyoto Encyclopedia of Genes and Genomes as substrates or products of the ~1900 metabolic enzymes encoded in our genome. It is clear in the body of literature that there are documented toxic properties for many of these metabolites[1]. |
| References |
| Molecular Formula | C27H46O5 |
|---|---|
| Molecular Weight | 450.65100 |
| Exact Mass | 450.33500 |
| PSA | 97.99000 |
| LogP | 4.47490 |
| Precursor 0 | |
|---|---|
| DownStream 2 | |